Research Article
Predictors of Effectiveness of Glucagon-Like Peptide-1 Receptor Agonist Therapy in Patients with Type 2 Diabetes and Obesity
| Parameters/visits | Screening | Visit 1 at baseline | Visit 2 after 24 months |
| Anthropometric parameters | + | + | + | Vital signs | + | + | + | Questionnaire survey | | + | + | Adiponectin | | + | + | GIP | | + | + | Leptin | | + | + | Ghrelin fasting | | + | + | Ghrelin after test | | + | + | GLP-1 | | + | + | НОМА-IR and НОМА-β | | + | + | C-peptide fasting | | + | + | C-peptide after meal test | | + | + | Lipid profile | | + | + | HbA1c | | + | + | Review of the therapy | + | + | + |
|
|
2 hours after breakfast in the meal tolerance test. |